HIGHLIGHTS
- who: Katharina Mayer from the , Munich, Germany have published the research work: High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry, in the Journal: (JOURNAL)
- what: The aim of this study was to assess the association between high on-aspirin treatment platelet reactivity (HAPR) and the subsequent risk of after (PCI) with predominantly stents. Methods This study included 4839 patients undergoing (02/2007-12/2011) the setting of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.